Showing results (801-810 of 1,120) with videos related to

Sort By:
Pageof 112
JAMA|March 6, 2023
Coordinated Care to Optimize Cardiovascular Preventive Therapies in Type 2 Diabetes: A Randomized Clinical TrialNeha J Pagidipati, Adam J Nelson, Lisa A Kaltenbach, et al.
European Heart Journal|May 24, 2019
Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trialHarvey D White, Ph Gabriel Steg, Michael Szarek, et al.
Lancet (London, England)|October 6, 2012
Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trialRenato D Lopes, Sana M Al-Khatib, Lars Wallentin, et al.
Journal of Cardiac Failure|January 12, 2024
Cardiac Troponin and Treatment Effects of Omecamtiv Mecarbil: Results From the GALACTIC-HF StudyG Michael Felker, Scott D Solomon, Marco Metra, et al.
The New England Journal of Medicine|November 5, 2021
Daprodustat for the Treatment of Anemia in Patients Undergoing DialysisAjay K Singh, Kevin Carroll, Vlado Perkovic, et al.
Immunology|January 26, 2023
Systemic immune mediators reflect tumour-infiltrating lymphocyte intensity and predict therapeutic response in triple-negative breast cancerAnanda D Lopes, Nayane A L Galdino, Amanda B Figueiredo, et al.
Circulation. Cardiovascular Interventions|July 13, 2026
Abbreviated Dual Antiplatelet Therapy in Patients With High Bleeding Risk Undergoing PCI of Bifurcation Lesions: A Prespecified Substudy of the MASTER DAPT TrialBernard Chevalier, Davide Cao, Pieter C Smits, et al.
Circulation|September 3, 2019
Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary SyndromesMatthew T Roe, Qian H Li, Deepak L Bhatt, et al.
Annals of Internal Medicine|June 21, 2021
Effect of Sotagliflozin on Total Hospitalizations in Patients With Type 2 Diabetes and Worsening Heart Failure : A Randomized TrialMichael Szarek, Deepak L Bhatt, Ph Gabriel Steg, et al.
Lancet (London, England)|September 2, 2017
A multifaceted intervention to improve treatment with oral anticoagulants in atrial fibrillation (IMPACT-AF): an international, cluster-randomised trialDragos Vinereanu, Renato D Lopes, M Cecilia Bahit, et al.
Pageof 112